Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
AACT
|
Ares Acquisition Holdings Ii LP |
BUY
Conversion of derivative security
|
Direct | 12,500,000 Added 50.0% |
-
|
Apr 22
2025 |
|
MGTX
|
Richard Giroux
CFO & COO |
SELL
Open market or private sale
|
Direct | 24,000 Reduced 2.65% |
$144,000
$6.0 p/Share
|
Apr 22
2025 |
|
EA
|
Andrew Wilson
Chairman & CEO |
SELL
Open market or private sale
|
Indirect | 5,000 Reduced 0.0% |
$726,700
$145.34 p/Share
|
Apr 22
2025 |
|
RBB
|
Lynn M Hopkins
EVP/CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 686 Reduced 22.69% |
$10,715
$15.62 p/Share
|
Apr 22
2025 |
|
RBB
|
Lynn M Hopkins
EVP/CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 1,917 Added 38.81% |
$29,943
$15.62 p/Share
|
Apr 22
2025 |
|
CDLX
|
Nicholas Hollmeyer Lynton
Chief Legal & Privacy Officer |
SELL
Open market or private sale
|
Direct | 303 Reduced 0.3% |
$457
$1.51 p/Share
|
Apr 22
2025 |
|
AVMR
|
Barry F Cohen
COO - Americas |
BUY
Open market or private purchase
|
Direct | 326 Added 0.0% |
$2,917
$8.95 p/Share
|
Apr 22
2025 |
|
RGLD
|
William Holmes Heissenbuttel
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 7,746 Reduced 5.84% |
$1,440,136
$185.92 p/Share
|
Apr 22
2025 |
|
RGLD
|
William Holmes Heissenbuttel
President & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct | 11,190 Reduced 7.99% |
$2,080,444
$185.92 p/Share
|
Apr 22
2025 |
|
RGLD
|
William Holmes Heissenbuttel
President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 28,840 Added 18.58% |
$2,388,240
$82.81 p/Share
|
Apr 22
2025 |
|
LIND
|
Alex P Schultz |
BUY
Open market or private purchase
|
Direct | 18,731 Added 5.84% |
$155,467
$8.3 p/Share
|
Apr 22
2025 |
|
CNTA
|
Saurabh Saha
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 40,344 Reduced 15.44% |
$501,475
$12.43 p/Share
|
Apr 22
2025 |
|
PCYG
|
Randall K Fields
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect | 6,500 Reduced 0.0% |
$129,415
$19.91 p/Share
|
Apr 22
2025 |
|
CYTK
|
Fady Ibraham Malik
EVP Research & Development |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 1.41% |
$76,220
$38.11 p/Share
|
Apr 22
2025 |
|
CYTK
|
Fady Ibraham Malik
EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct | 2,000 Added 1.39% |
$21,200
$10.6 p/Share
|
Apr 22
2025 |
|
FRAF
|
Mark R Hollar
EVP/CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 514 Added 3.74% |
$13,811
$26.87 p/Share
|
Apr 22
2025 |
|
NEOG
|
Jeffrey D Capello
Director |
BUY
Open market or private purchase
|
Direct | 20,712 Added 43.75% |
$100,246
$4.84 p/Share
|
Apr 22
2025 |
|
NEOG
|
James P Tobin
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 21.06% |
$47,300
$4.73 p/Share
|
Apr 22
2025 |
|
NEOG
|
Rafael A Rodriguez
Director |
BUY
Open market or private purchase
|
Direct | 7,474 Added 33.33% |
$34,305
$4.59 p/Share
|
Apr 22
2025 |
|
NTRA
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct | 86 Reduced 0.03% |
$12,543
$145.85 p/Share
|
Apr 21
2025 |
|
NTRA
|
Daniel Rabinowitz
SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct | 470 Reduced 0.21% |
$68,549
$145.85 p/Share
|
Apr 21
2025 |
|
NTRA
|
Solomon Moshkevich
PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct | 296 Reduced 0.21% |
$43,275
$146.2 p/Share
|
Apr 21
2025 |
|
NTRA
|
John Fesko
PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct | 343 Reduced 0.22% |
$50,016
$145.82 p/Share
|
Apr 21
2025 |
|
NTRA
|
Steven Leonard Chapman
CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct | 1,664 Reduced 0.83% |
$242,627
$145.81 p/Share
|
Apr 21
2025 |
|
NTRA
|
Michael Burkes Brophy
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 610 Reduced 0.79% |
$88,968
$145.85 p/Share
|
Apr 21
2025 |
|
IMII
|
Whitney O Cluff
Director |
BUY
Open market or private purchase
|
Indirect | 500 Added 0.0% |
$270
$0.54 p/Share
|
Apr 21
2025 |
|
SCHW
|
Frank C Herringer
Director |
SELL
Open market or private sale
|
Indirect | 3,592 Reduced 0.0% |
$266,741
$74.26 p/Share
|
Apr 21
2025 |
|
SCHW
|
Frank C Herringer
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 8,548 Added 48.15% |
$266,783
$31.21 p/Share
|
Apr 21
2025 |
|
ROIV
|
Eric Venker
President & COO |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 8.22% |
$1,022,000
$10.22 p/Share
|
Apr 21
2025 |
|
ROIV
|
Eric Venker
President & COO |
BUY
Exercise of conversion of derivative security
|
Direct | 100,000 Added 7.6% |
$385,000
$3.85 p/Share
|
Apr 21
2025 |
|
RDI
|
Ellen M Cotter
Director, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 15,577 Added 1.57% |
-
|
Apr 21
2025 |
|
CRWD
|
Johanna Flower |
SELL
Open market or private sale
|
Direct | 2,974 Reduced 3.46% |
$1,081,673
$363.71 p/Share
|
Apr 21
2025 |
|
NFLX
|
Jeffrey William Karbowski
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 160 Reduced 100.0% |
$160,000
$1000.0 p/Share
|
Apr 21
2025 |
|
NFLX
|
Jeffrey William Karbowski
Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 160 Added 50.0% |
$62,676
$391.73 p/Share
|
Apr 21
2025 |
|
RDI
|
Margaret Cotter
Chairperson, EVP - RE Dev/NY |
BUY
Exercise of conversion of derivative security
|
Direct | 11,390 Added 1.33% |
-
|
Apr 21
2025 |
|
EBF
|
Daniel Gus
General Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct | 1,802 Added 10.24% |
-
|
Apr 21
2025 |
|
EBF
|
Boyne Wade Brewer
Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 1,802 Added 8.59% |
-
|
Apr 21
2025 |
|
EBF
|
Vera Burnett
CFO and Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct | 1,802 Added 6.15% |
-
|
Apr 21
2025 |
|
LHX
|
Edward A Rice Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 887 Added 23.9% |
-
|
Apr 21
2025 |
|
LHX
|
Christina L Zamarro
Director |
BUY
Grant, award, or other acquisition
|
Direct | 887 Added 15.4% |
-
|
Apr 21
2025 |
|
QLYS
|
Bruce K Posey
CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct | 540 Reduced 0.83% |
$63,990
$118.5 p/Share
|
Apr 21
2025 |
|
LHX
|
David S Regnery
Director |
BUY
Grant, award, or other acquisition
|
Direct | 887 Added 37.47% |
-
|
Apr 21
2025 |
|
LHX
|
Rita S. Lane
Director |
BUY
Grant, award, or other acquisition
|
Direct | 887 Added 10.6% |
-
|
Apr 21
2025 |
|
LHX
|
Robert B Millard
Director |
BUY
Grant, award, or other acquisition
|
Direct | 887 Added 7.73% |
-
|
Apr 21
2025 |
|
SEAT
|
Edward Pickus
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 534 Reduced 0.58% |
$1,201
$2.25 p/Share
|
Apr 21
2025 |
|
SEAT
|
Riva Bakal
Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 1,125 Reduced 0.42% |
$2,531
$2.25 p/Share
|
Apr 21
2025 |
|
ELF
|
Joshua Allen Franks
SVP, Operations |
SELL
Open market or private sale
|
Direct | 51,353 Reduced 30.93% |
$2,740,196
$53.36 p/Share
|
Apr 21
2025 |
|
LHX
|
Lewis Hay Iii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 887 Added 11.74% |
-
|
Apr 21
2025 |
|
ELF
|
Kory Marchisotto |
SELL
Open market or private sale
|
Direct | 51,350 Reduced 25.19% |
$2,740,036
$53.36 p/Share
|
Apr 21
2025 |
|
ELF
|
Tarang Amin
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 97,915 Reduced 35.07% |
$5,224,744
$53.36 p/Share
|
Apr 21
2025 |